News Press Contact: Kirsten Mabry | (617) 495-4157

In a recent Guppy Tank event, Professor Jeffrey Smith received feedback from a panel of investors on a new molecule that could help most sun-sensitive patients, research supported by the Blavatnik Biomedical Accelerator. Harvard's Office of Technology Development and LabCentral co-host the Guppy Tank series, where innovators pitch their early-stage concepts to a panel of entrepreneurs and investors for constructive, in-depth feedback.

For more than three decades, Greg Verdine has brought bold, innovative methods to solving some of medicine’s biggest challenges - from early-stage work backed by the Harvard Blavatnik Biomedical Accelerator to the launch of multiple startups.

Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences built a device called a pico-calorimeter that directly measures heat signals from small groups of living cells. The device could lead to advances in bacterial growth monitoring or antibiotic resistance testing.

Harvard University has expanded a research alliance agreement with Northpond Labs to fund translational research, accelerate commercialization, and advance breakthrough healthcare innovations across Harvard labs at the Wyss Institute, Harvard Medical School, John A. Paulson School of Engineering and Applied Sciences, and Faculty of Arts and Sciences.